Results 161 to 170 of about 3,601 (174)

[Topoisomerase I inhibitor (irinotecan hydrochloride)].

Nihon rinsho. Japanese journal of clinical medicine, 2005
Shoichi, Inoue, Mohamed Kamel, Hassan, Akio, Kanetoshi   +2 more
openaire   +1 more source

Recurrent cervical cancer in a patient who was compound heterozygous for UGT1A1*6 and UGT1A1*28 presenting with serious adverse events during irinotecan hydrochloride/nedaplatin therapy

Journal of Obstetrics and Gynaecology Research, 2013
Eriko Takatori, Tadahiro Shoji, Satoshi Takeuchi   +2 more
exaly  

Irinotecan hydrochloride.

Clinical journal of oncology nursing, 2003
openaire   +1 more source

Modified irinotecan hydrochloride (CPT-11) administration schedule improves induction of delayed-onset diarrhea in rats

Cancer Chemotherapy and Pharmacology, 2000
Akinobu Kurita, Norimasa Kaneda, Shusuke Hashimoto   +2 more
exaly  

Synthesis and Antitumor Activity of A-Ring or E-Lactone Modified Water­ Soluble Prodrugs of 20(S)-Camptothecin, Including Development of Irinotecan Hydrochloride Trihydrate (CPT-11)

Current Pharmaceutical Design, 1995
T Yokokura
exaly  

Irinotecan Hydrochloride

openaire   +1 more source

Phase I Study of a Weekly Infusion of Irinotecan Hydrochloride (CPT-11) and a 14-day Continuous Infusion of Etoposide in Patients with Lung Cancer: JCOG Trial 9408

Japanese Journal of Clinical Oncology, 2000
T Shinkai, H Kunitoh, I Sekine
exaly  

[Irinotecan hydrochloride for treatment of advanced breast cancers].

Nihon rinsho. Japanese journal of clinical medicine, 2000
K, Morimoto, M, Kou, H, Kinoshita
openaire   +1 more source

Retrospective Investigation of Constipation Occurrence in Case of Combined Use of Irinotecan Hydrochloride (CPT-11) and Hange-shashin-to and Relationship with CPT-11 Dose

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences), 2009
Koujiro Futagami
exaly  

Irinotecan Hydrochloride Liposomal

openaire   +1 more source